| Name | Title | Contact Details |
|---|---|---|
Michael Brubeck |
Chief Human Ambassador | Profile |
TermScout is a Denver-based legal-tech company that helps businesses review contracts smarter and faster.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Mold Law Groups litigation platform is a culmination of over 15 years of in-depth research by environmentalists, epidemiologists, toxicologists, medical professionals, Neurotoxicologists, Neuropsychologists, and law firms. Our proven methodology, for the first time, provides litigators the ability to couple the human pathogens in an environment to the direct causation of disease within the human body. The development of this cutting-edge science required an understanding of many different scientific disciplines and medical philosophies to provide a unique and new model for mold litigation. This platform is designed to defend or prosecute property and medical damages caused by mold and microbial exposure. Using precision based DNA-PCR sequencing, bacteria culturing, endotoxin testing, (1—>3)β-D beta glucan and other advanced environmental and medical testing, we leverage cutting edge technology and advanced mold litigation techniques to provide our clients with unparalleled and detailed services found nowhere else in our industry. Mold Law Group offers expert witnesses, consulting services, medical resources, legal resources, and environmental resources. We offer these services nationally and internationally. Mold Law Group is the absolute gold standard when it comes to mold litigation consulting.
ChromaScape is a specialty chemicals company based in Independence, Ohio, with a production facility in Stow. Founded in 1998, it has roots dating back to 1968. The company operates six manufacturing and distribution facilities across the U.S. and boasts over 100 years of combined expertise in colorant formulation and supply chain management. ChromaScape focuses on lean manufacturing, digital integration, and customer-centric processes to enhance quality and efficiency. ChromaScape offers a range of products, including colorants and additives for various industries. In landscaping, it provides Amerimulch® colored mulch and rubber/aggregate colorants. For packaging, it supplies Aquablak® aqueous carbon black dispersions and CEL Chemical adhesives for waterproof corrugated board. In construction, its Innotech® decorative concrete colorants and ChromaPave® asphalt sealcoat colorants are widely used. The company has expanded its portfolio through strategic acquisitions, enhancing its offerings in printing, packaging, and consumer specialties.